Terms: = Prostate cancer AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3
17 results:
1. Disparities Associated with Shared Decision-making in prostate cancer Screening.
Basin MF; Crane K; Basnet A; Chandrasekar T; Shapiro O; Jacob JM; Bratslavsky G; Goldberg H
Eur Urol Focus; 2023 Nov; 9(6):1008-1015. PubMed ID: 37198068
[TBL] [Abstract] [Full Text] [Related]
2. miR-221-5p enhances cell proliferation and metastasis through post-transcriptional regulation of socs1 in human prostate cancer.
Shao N; Ma G; Zhang J; Zhu W
BMC Urol; 2018 Mar; 18(1):14. PubMed ID: 29506516
[TBL] [Abstract] [Full Text] [Related]
3. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract] [Full Text] [Related]
4. Expression of socs1 and the downstream targets of its putative tumor suppressor functions in prostate cancer.
Chevrier M; Bobbala D; Villalobos-Hernandez A; Khan MG; Ramanathan S; Saucier C; Ferbeyre G; Geha S; Ilangumaran S
BMC Cancer; 2017 Feb; 17(1):157. PubMed ID: 28235401
[TBL] [Abstract] [Full Text] [Related]
5. socs1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of Circulating Tumor Cells in prostate cancer Patients at PSA Recurrence and Review of the Literature.
Grisanti S; Antonelli A; Buglione M; Almici C; Foroni C; Sodano M; Triggiani L; Greco D; Palumbo C; Marini M; Magrini SM; Berruti A; Simeone C
Anticancer Res; 2016 Jun; 36(6):2975-81. PubMed ID: 27272813
[TBL] [Abstract] [Full Text] [Related]
7. Synthesis, characterization and theoretical calculations of (1,2-diaminocyclohexane)(1,3-diaminopropane)gold(III) chloride complexes: in vitro cytotoxic evaluations against human cancer cell lines.
Al-Jaroudi SS; Altaf M; Al-Saadi AA; Kawde AN; Altuwaijri S; Ahmad S; Isab AA
Biometals; 2015 Oct; 28(5):827-44. PubMed ID: 26099502
[TBL] [Abstract] [Full Text] [Related]
8. Suppressors of cytokine signalling-3 and -1 in human carcinogenesis.
Culig Z
Front Biosci (Schol Ed); 2013 Jan; 5(1):277-83. PubMed ID: 23277051
[TBL] [Abstract] [Full Text] [Related]
9. Identification of miR-30d as a novel prognostic maker of prostate cancer.
Kobayashi N; Uemura H; Nagahama K; Okudela K; Furuya M; Ino Y; Ito Y; Hirano H; Inayama Y; Aoki I; Nagashima Y; Kubota Y; Ishiguro H
Oncotarget; 2012 Nov; 3(11):1455-71. PubMed ID: 23231923
[TBL] [Abstract] [Full Text] [Related]
10. Overexpression of signal transducer and activator of transcription (STAT-3 and STAT-5) transcription factors and alteration of suppressor of cytokine signaling (socs-1) protein in prostate cancer.
Singh N; Hussain S; Bharadwaj M; Kakkar N; Singh SK; Sobti RC
J Recept Signal Transduct Res; 2012 Dec; 32(6):321-7. PubMed ID: 23134344
[TBL] [Abstract] [Full Text] [Related]
11. LNCaP prostate cancer cells with autocrine interleukin-6 expression are resistant to IL-6-induced neuroendocrine differentiation due to increased expression of suppressors of cytokine signaling.
Ge D; Gao AC; Zhang Q; Liu S; Xue Y; You Z
Prostate; 2012 Sep; 72(12):1306-16. PubMed ID: 22213096
[TBL] [Abstract] [Full Text] [Related]
12. Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases.
Neuwirt H; Puhr M; Santer FR; Susani M; Doppler W; Marcias G; Rauch V; Brugger M; Hobisch A; Kenner L; Culig Z
Am J Pathol; 2009 May; 174(5):1921-30. PubMed ID: 19342366
[TBL] [Abstract] [Full Text] [Related]
13. Laparoscopic radical prostatectomy: six months of fellowship training doesn't prevent the learning curve when incorporating into a lower volume practice.
Brown JA; Sajadi KP
Urol Oncol; 2009; 27(2):144-8. PubMed ID: 18367119
[TBL] [Abstract] [Full Text] [Related]
14. Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.
Singh AP; Bafna S; Chaudhary K; Venkatraman G; Smith L; Eudy JD; Johansson SL; Lin MF; Batra SK
Cancer Lett; 2008 Jan; 259(1):28-38. PubMed ID: 17977648
[TBL] [Abstract] [Full Text] [Related]
15. Expression of socs1 and SOCS3 genes is differentially regulated in breast cancer cells in response to proinflammatory cytokine and growth factor signals.
Evans MK; Yu CR; Lohani A; Mahdi RM; Liu X; Trzeciak AR; Egwuagu CE
Oncogene; 2007 Mar; 26(13):1941-8. PubMed ID: 17001312
[TBL] [Abstract] [Full Text] [Related]
16. Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer.
Suzuki M; Shigematsu H; Shivapurkar N; Reddy J; Miyajima K; Takahashi T; Gazdar AF; Frenkel EP
Cancer Lett; 2006 Oct; 242(2):222-30. PubMed ID: 16458425
[TBL] [Abstract] [Full Text] [Related]
17. A socs-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.
Flowers LO; Subramaniam PS; Johnson HM
Oncogene; 2005 Mar; 24(12):2114-20. PubMed ID: 15688010
[TBL] [Abstract] [Full Text] [Related]